RxDoctor Payments Data

Jodi Turano, DO

Obstetrics & Gynecology · Paragould, ARNPI 1639340599

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 58.5% of the total. 2025 is the largest year on record at $354, more than ten times the $23 reported in 2019. That places this record below the midpoint for obstetrics & gynecology clinicians in AR, where the typical reported total is $1,340.

$1,032in general payments, 2019–2025

Across 47 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$603
  • Biogen$114
  • Medtronic$51
  • Bayer$38
  • AstraZeneca$32
  • Novo Nordisk$31
  • plus $163 from 9 others

What the payments were for

  • Food & beverage$1,02599%
  • Education$71%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,032 in reported general payments places this provider in the 40th percentile of 272 obstetrics & gynecology providers in Arkansas.

See all obstetrics & gynecology providers in Arkansas →

Medicare billing

Part B allowed, 2024
$6,220
Medicare patients
30
Services billed
80

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol17$362

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Paragould

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →